0001985382-24-000002.txt : 20240718 0001985382-24-000002.hdr.sgml : 20240718 20240718121104 ACCESSION NUMBER: 0001985382-24-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20240718 DATE AS OF CHANGE: 20240718 EFFECTIVENESS DATE: 20240718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invenomic Offshore Fund LP CENTRAL INDEX KEY: 0001985382 ORGANIZATION NAME: IRS NUMBER: 981656319 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-487253 FILM NUMBER: 241124128 BUSINESS ADDRESS: STREET 1: C/O INVENOMIC PRIVATE FUND GP LLC STREET 2: 211 CONGRESS STREET, 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-549-6076 MAIL ADDRESS: STREET 1: C/O INVENOMIC PRIVATE FUND GP LLC STREET 2: 211 CONGRESS STREET, 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 D/A 1 primary_doc.xml X0708 D/A LIVE 0001985382 Invenomic Offshore Fund LP C/O INVENOMIC PRIVATE FUND GP LLC 211 CONGRESS STREET, 8TH FLOOR BOSTON MA MASSACHUSETTS 02110 617-549-6076 CAYMAN ISLANDS None None Limited Partnership true 2020 N/A Invenomic Private Fund GP LLC c/o Ogier Global (Cayman) Limited 89 Nexus Way Camana Bay E9 CAYMAN ISLANDS KY1-9009 Executive Officer Promoter General Partner of the Issuer N/A Invenomic Offshore Fund LP c/o Invenomic Private Fund GP LLC 211 Congress Street, 8th Floor Boston MA MASSACHUSETTS 02110 Executive Officer Managing Partner of the General Partner of the Issuer N/A Invenomic Capital Management LP 211 Congress Street 8th Floor Boston MA MASSACHUSETTS 02110 Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000898432-23-000509 2023-07-03 true true true Limited partnership interests. The minimum investment amount of $1,000,000 may be waived by the General Partner in its sole discretion. false 0 Indefinite 191389966 Indefinite false 40 0 true 0 true 0 true Certain persons named in Item 3 or affiliates(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amounts of such payments cannot be estimated at this time. false Invenomic Offshore Fund LP /s/ Benjamin Deschaine Benjamin Deschaine Managing Partner of the General Partner of the Issuer 2024-07-18